Fitzpatrick Meagan C, Shah Hiral A, Pandey Abhishek, Bilinski Alyssa M, Kakkar Manish, Clark Andrew D, Townsend Jeffrey P, Abbas Syed Shahid, Galvani Alison P
Center for Infectious Disease Modeling and Analysis, Yale School of Public Health, New Haven, CT 06510.
Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD 21201.
Proc Natl Acad Sci U S A. 2016 Dec 20;113(51):14574-14581. doi: 10.1073/pnas.1604975113.
Over 20,000 rabies deaths occur annually in India, representing one-third of global human rabies. The Indian state of Tamil Nadu has pioneered a "One Health" committee to address the challenge of rabies in dogs and humans. Currently, rabies control in Tamil Nadu involves postexposure vaccination of humans after dog bites, whereas potential supplemental approaches include canine vaccination and sterilization. We developed a data-driven rabies transmission model fit to human rabies autopsy data and human rabies surveillance data from Tamil Nadu. Integrating local estimates for canine demography and costs, we predicted the impact of canine vaccination and sterilization on human health outcomes and evaluated cost-effectiveness according to the WHO criteria for India, which correspond to thresholds of $1,582 and $4,746 per disability-adjusted life-years (DALYs) for very cost-effective and cost-effective strategies, respectively. We found that highly feasible strategies focused on stray dogs, vaccinating as few as 7% of dogs annually, could very cost-effectively reduce human rabies deaths by 70% within 5 y, and a modest expansion to vaccinating 13% of stray dogs could cost-effectively reduce human rabies by almost 90%. Through integration over parameter uncertainty, we find that, for a cost-effectiveness threshold above $1,400 per DALY, canine interventions are at least 95% likely to be optimal. If owners are willing to bring dogs to central point campaigns at double the rate that campaign teams can capture strays, expanded annual targets become cost-effective. This case study of cost-effective canine interventions in Tamil Nadu may have applicability to other settings in India and beyond.
印度每年有超过2万例狂犬病死亡病例,占全球人类狂犬病死亡病例的三分之一。印度泰米尔纳德邦率先成立了一个“同一健康”委员会,以应对犬类和人类狂犬病的挑战。目前,泰米尔纳德邦的狂犬病防控措施包括在人类被狗咬伤后进行暴露后疫苗接种,而潜在的补充措施包括犬类疫苗接种和绝育。我们开发了一个数据驱动的狂犬病传播模型,该模型与来自泰米尔纳德邦的人类狂犬病尸检数据和人类狂犬病监测数据相匹配。结合当地对犬类人口统计学和成本的估计,我们预测了犬类疫苗接种和绝育对人类健康结果的影响,并根据世界卫生组织针对印度的标准评估了成本效益,该标准分别对应于每残疾调整生命年(DALY)1582美元和4746美元的阈值,用于定义非常具有成本效益和具有成本效益的策略。我们发现,高度可行的策略聚焦于流浪狗,每年只需给7%的狗接种疫苗,就能在5年内非常经济高效地将人类狂犬病死亡病例减少70%,适度扩大到给13%的流浪狗接种疫苗,则能经济高效地将人类狂犬病死亡病例减少近90%。通过对参数不确定性进行综合分析,我们发现,对于每DALY成本效益阈值高于1400美元的情况,犬类干预措施至少有95%的可能性是最优的。如果狗主人愿意以活动团队捕获流浪狗速度的两倍,将狗带到集中接种活动现场,那么扩大后的年度目标将具有成本效益。泰米尔纳德邦这种具有成本效益的犬类干预措施的案例研究可能适用于印度及其他地区的其他情况。